Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Inhibitors of ICE activity described by Vertex

Sep. 14, 1998

Merck & Co. discovers another potent and selective COX-2 inhibitor

Sep. 11, 1998

Merck Frosst reveals discoveries in the field of COX-2 inhibitors at ACS meeting

Sep. 11, 1998

Kotobuki selects development candidate from novel series with selectivity for COX-2

Sep. 11, 1998

Merck's COX-2 inhibitor Vioxx shown safe and effective in clinical trials

Sep. 10, 1998

MMP inhibitor PGE-2946979 shows good oral antiarthritic activity in rats

Sep. 10, 1998

Astra presents data on novel series of cPLA2 inhibitors

Sep. 9, 1998

Enbrel efficacy demonstrated in juvenile RA patients

Sep. 7, 1998

MDX-CD4 development progresses, triggering milestone payment from Eisai

Sep. 7, 1998

Substituted pyrimidines from Amgen inhibit cytokine production

Sep. 7, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...